Tyra Biosciences Stock Revenue
| TYRA Stock | USD 10.37 0.56 5.12% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Tyra Biosciences' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Tyra Biosciences Company Revenue Analysis
Tyra Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Tyra Biosciences reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Tyra Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tyra Biosciences' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics of similar companies.Tyra Biosciences is currently under evaluation in revenue category among its peers.
Tyra Fundamentals
| Return On Equity | -0.27 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | 238.1 M | ||||
| Shares Outstanding | 53.18 M | ||||
| Shares Owned By Insiders | 3.68 % | ||||
| Shares Owned By Institutions | 96.32 % | ||||
| Number Of Shares Shorted | 6.04 M | ||||
| Price To Earning | (3.33) X | ||||
| Price To Book | 1.70 X | ||||
| EBITDA | (85.96 M) | ||||
| Net Income | (86.48 M) | ||||
| Cash And Equivalents | 275.11 M | ||||
| Cash Per Share | 6.61 X | ||||
| Total Debt | 6.22 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 50.83 X | ||||
| Book Value Per Share | 6.09 X | ||||
| Cash Flow From Operations | (69.77 M) | ||||
| Short Ratio | 16.76 X | ||||
| Earnings Per Share | (1.63) X | ||||
| Price To Earnings To Growth | 0.28 X | ||||
| Target Price | 30.14 | ||||
| Number Of Employees | 60 | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 551.46 M | ||||
| Total Asset | 363.56 M | ||||
| Retained Earnings | (251.31 M) | ||||
| Working Capital | 332.87 M | ||||
| Net Asset | 363.56 M |
About Tyra Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tyra Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tyra Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tyra Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tyra Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tyra Biosciences Stock:Check out Tyra Biosciences Piotroski F Score and Tyra Biosciences Altman Z Score analysis. For information on how to trade Tyra Stock refer to our How to Trade Tyra Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tyra Biosciences. If investors know Tyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tyra Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tyra Biosciences is measured differently than its book value, which is the value of Tyra that is recorded on the company's balance sheet. Investors also form their own opinion of Tyra Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Tyra Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tyra Biosciences' market value can be influenced by many factors that don't directly affect Tyra Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tyra Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tyra Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tyra Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.